Search Results - Donna R. Burgess

Changing times: The impact of gram-negative breakpoint changes over the previous decade by Wes M. Johnson, Justin A. Clark, Katherine Olney, Donna R. Burgess, David S. Burgess

Connect to this object online.

Utilizing Monte Carlo Simulations to Optimize Institutional Empiric Antipseudomonal Therapy by Sarah J. Tennant, Donna R. Burgess, Jeffrey M. Rybak, Craig A. Martin, David S. Burgess

Connect to this object online.

Respiratory Muscle Paralysis Associated With Colistin, Polymyxin B, and Muscle Relaxants Drugs by Thein Myint MBBS, Martin E. Evans MD, Donna R. Burgess RPh, Richard N. Greenberg MD

Connect to this object online.

Appropriateness of antibiotic use in patients with and without altered mental status diagnosed with a urinary tract infection by Connor M. Anderson, Jeremy D. VanHoose, Donna R. Burgess, David S. Burgess, Aric Schadler, J. Zachary Porterfield, Katie L. Wallace

Connect to this object online.

Association of vancomycin-induced acute kidney injury with trough versus AUC monitoring in patients receiving extended durations of therapy by C. Tyler Pitcock, Aric Schadler, David S. Burgess, Donna R. Burgess, Sarah E. Cotner, Jeremy Van Hoose, Eric R. Gregory, Katie L. Wallace

Connect to this object online.

The impact of coronavirus disease 2019 (COVID-19) on the antimicrobial stewardship pharmacist workforce: A multicenter survey by Megan R. Wimmer, Lucas T. Schulz, Ashlee G. Hamel, Rebecca J. Schwei, Karen Fong, Donna R. Burgess, Meghan Brett, Cory M. Hale, Marisa Holubar, Rupali Jain, Rachel Larry, Emily S. Spivak, Helen Newland, Jessica Njoku, Michael Postelnick, Carla Walraven, Michael S. Pulia

Connect to this object online.